Emend 125 mg shortage: what substitute treatment for patients?

A supply shortage of oral Emend 125 mg anti-emetic affects patients treated for chemotherapy-related nausea.

Published 12sem2 sources✓ Confirmedupdated 11sem

≈ 21sSpeed

The fact

This medication, important for improving tolerability of anticancer treatments, is becoming unavailable in the French market.

Health authorities and pharmaceutical industry are seeking alternative solutions and replacement routes.

2 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 2 media sources · identified on April 24, 2026